Cardiology other Flashcards

1
Q

how long should you wait to prescribe sildenafil post MI

A

6 months post MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which beta blockers have been shown to reduce mortality in HF

A

carvedilol and bisoprolol are the only BBs that have been shown to reduce mortality in stable heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Side effects of Adenosine administration (SVT)

A

Flushing
chest and abdo discomfort
headache
hypotension

an ‘impending sense of doom’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are some secondary causes of AF and why

A

IHD: ischemia → scarring → electrical insability.

Heart failure, HTN, valvular disease, PE:
pressure → atrial enlargement → electrical instability.

Hyperthyroidism and stimulants
increased HR → increased atrial activity.

OSA and COPD:
Oxygen deprivation → atrial remodeling.

EtoH and smoking:
Toxic effects on heart cells → electrical disruption.

Sepsis: Widespread inflammation

Electrolyte Imbalances: electrical instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

doses of NOACs to start on for AF

A

Dabigatrain
- 150mg BD if <80 and CrCl >50
- 110mg BD if >80 or lower CrCl 30-50

Rivaroxaban
- 20mg OD if CrCl >50
- 15mg OD if CrCl 15-49

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Doses of Beta-blockers to start on for AF rate control
(and which ones do you choose?)

A

Bisoprolol 1.25-20mg
metoprolol 23.75-190mg
Carvedilol 3.125-50mg

avoid sotalol as it can cause arrhythmias/heart block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Doses of calcium-channel-blockers to start on for AF rate control
(and which ones do you choose?)

A

non-dihydropyridine CCB
1. Diltiazem
IR 60mg TDS
MR 120mg OD

  1. Verapamil:
    IR 40mg TDS
    MR 120mg OD

DO NOT USE VERAPAMIL with a BB - negative inotrope and hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what would be some reasons warfarin would be preferable over DOACs for AF

A

Mechanical valve or mod-severe mitral stenosis

Severe renal or liver disease
Significant gastrointestinal disease: Standard-dose DOACs have a higher risk of gastrointestinal bleeding than warfarin; lower doses have comparable risk.
Antiphospholipid syndrome:

if DOACs trialled/not working/adverse affects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Managing bleeding on a DOAC

A

mild bleeding:
compression + supportive measures
TXA
WH DOAC for 1-2 days

moderate - severe:
discuss with haem, ABCD, refer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

whats a common GI symptom of dabigatran to be aware of

A

dyspepsia (~30%)
Take post prandially or with PPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why do we worry about LBBB

A

because they are always pathological

myocardial infarction
HTN
aortic stenosis
cardiomyopathy
rare: idiopathic fibrosis, digoxin toxicity, hyperkalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how long do you see STE post STEMI, and what does it mean if they persist

A

ST elevation
- typically begins to resolve within hours to days after reperfusion or treatment, often normalizes within 1 to 2 weeks
- may persist longer if there is extensive myocardial damage or if the infarcted area does not fully recover.

Chronic Changes: Persistent ST elevation beyond several weeks can indicate left ventricular aneurysm formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how long do you see STD post NSTEMI, a

A

ST depression tends to normalize faster than ST elevation

often within a few days, especially if the ischemia is relieved and no further myocardial injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Summarise HOCM, its inheritence and ECHO findings

A

Hypertrophic obstructive cardiomyopathy (HOCM) autosomal dominant condition of muscle tissue caused by defects in the genes encoding contractile proteins.

HOCM is important as it is the most common cause of sudden cardiac death in the young (leads to VF)

ECHOL MR SAM ASH (MR, systolic movment of mitral valve, asymmetric hypertrophy_

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Features of hypokalaemia on ECG

A

U waves
small or absent T waves (occasionally inversion)
prolong PR interval
ST depression
long QT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

o

Features of hyperkalaemia on ECG

A

Peaked T waves
Widened QRS complex
Prolonged PR interval
Flattened or absent P waves

17
Q

recap - what actually is BNP

A

hormone produced by cardiomyocytes in response to increased ventricle wall tension

aka an indication of how “stressed” the heart is

primarily to be a “rule out” test, (unless super high) as other conditions can also affect levels

18
Q

What things increase BNP
What things decrease BNP

A

Increase: AGE, HF, AF, COPD or left ventricular hypertrophy

Decrease: obesity, hypothyroidism, diuretics, ACE inhibitors

19
Q

non pharmacological management of HF

A

Weight loss
fluid restriction 1.5-2L/day
Salt restriction <2-3g/day
Annual influenza and pneumococcal
Reduce EtoH and smoking
Manage comorbidities

20
Q

What % increase in Cr is acceptable after starting an ACE i

A

An increase in serum creatinine of up to 30% above baseline is acceptable following initiation of an ACE inhibitor assuming it does not exceed 250 micromol/L

21
Q

Special authority criteria for Entresto (sacubitril/valsartan)

A

NYHA class II-IV

ECHO showing LVEF <35% or if ECHO is not practically possible if the clinician believes they are “likely to benefit from treatment”

Patient is receiving concomitant optimal standard chronic heart failure treatments

22
Q

How wquickly can you start an ARNI after stopping an ACEi/ARB, and what should you monitor

A

Wait until 36 hours post last dose of ACEi or 24hrs after last dose of ABR (angioodema risk)

BP + UEs (specifically potassium) should be monitored at the start, with every dose increase and then every six months

23
Q

the

When should you start digoxin for a HF patient.

A

Consider digoxin if patients have heart failure associated with atrial fibrillation and symptoms cannot be adequately controlled with a beta-blocker

There is some evidence this medicine may improve symptoms and reduce the rate of hospitalisation, however, it does not improve survival

24
Q

why do you get iron deficiency with heart failure

A
  • Inflammation → hepicidin → reduced iron absorption
  • CKD → reduced EPO
  • fluid overload → dilutional anaemia

IDA in HF is associated ith worse clinical outcomes

25
Q

drugs that cause long QT

A

amiodarone, sotalol, class 1a antiarrhythmic drugs
tricyclic antidepressants, selective serotonin reuptake inhibitors (especially citalopram)
methadone
chloroquine
terfenadine**
erythromycin
haloperidol
ondanestron

26
Q

Who should get aspirin

A

patients aged under 70 years with :
≥ 15% five-year CVD risk.
coronary disease
carotid disease (plaque on ultrasound)
high coronary calcium score on CT scan (> 400)

27
Q

What are the criteria to start a lipid lowering medication

A

any hx of CVD
a TC:HDL-C ratio of ≥ 8 despite lifestyle interventions
CVDRA 5-15% w consideration
CVDRA >15%

or very high triglyceride levels (≥ 11 mmol/L) due to pancreatitis risk

28
Q

SEs of ACEis

A
  • hyperkalaemia
  • dry cough
  • angioedema (up to 1 yr post starting)